Expression of AdipoR1 and AdipoR2 Receptors As Leptin-Breast Cancer Regulation Mechanisms

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2018 Jan 10

PMID 29311755

Citations 9

Authors

Martha Daniela Mocino-Rodriguez

Jonnathan Guadalupe Santillan-Benitez

David Salomon Dozal-Dominguez

Maria Dolores Hernandez-Navarro

Miriam Veronica Flores-Merino

Antonio Sandoval-Cabrera

Francisco Javier Garcia Vazquez

Affiliations

Soon will be listed here.

Abstract

The development of breast cancer is influenced by the adipose tissue through the proteins leptin and adiponectin. However, there is little research concerning AdipoR1 and AdipoR2 receptors and the influence of leptin over them. The objective of this work was to analyze the expression of AdipoR1 and AdipoR2, modulated by differential concentrations of leptin in an obesity model (10 ng/mL, 100 ng/mL, and 1000 ng/mL) associated with breast cancer in MCF-7 and HCC1937 cell lines. Each cell line was characterized through immunohistochemistry, and the expression of AdipoR1 and AdipoR2 was analyzed by PCR in real time using TaqMan® probes. Leptin induced an increase in cell population of MCF-7 (23.8%, 10 ng/mL, 48 h) and HCC1937 (17.24%, 1000 ng/mL, 72 h). In MCF-7, the expression of AdipoR1 decreased (3.81%, 1000 ng/mL) and the expression of AdipoR2 increased by 13.74 times (10 ng/mL) with regard to the control. In HCC1937, the expression of AdipoR1 decreased by 86.28% (10 ng/mL), as well as the expression of AdipoR2 (50.3%, 100 ng/mL). In regard to the results obtained, it could be concluded that leptin has an effect over the expression of AdipoR1 and AdipoR2 mRNA.

Citing Articles

Role of adipocytokines in endometrial cancer progression.

Li R, Dong F, Zhang L, Ni X, Lin G Front Pharmacol. 2022; 13:1090227.

PMID: 36578551 PMC: 9791063. DOI: 10.3389/fphar.2022.1090227.

Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer.

Papakonstantinou E, Piperigkou Z, Karamanos N, Zolota V Cancers (Basel). 2022; 14(17).

PMID: 36077676 PMC: 9454958. DOI: 10.3390/cancers14174139.

The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis.

Umar M, Hassan W, Murtaza G, Buabeid M, Arafa E, Irfan H Pathol Oncol Res. 2021; 27:1609828.

PMID: 34588926 PMC: 8473628. DOI: 10.3389/pore.2021.1609828.

Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.

Llanos A, Yao S, Singh A, Aremu J, Khiabanian H, Lin Y Breast Cancer Res Treat. 2020; 185(3):785-798.

PMID: 33067778 PMC: 7925351. DOI: 10.1007/s10549-020-05972-0.

A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment.

Kadye R, Stoffels M, Fanucci S, Mbanxa S, Prinsloo E Cells. 2020; 9(4).

PMID: 32331320 PMC: 7226520. DOI: 10.3390/cells9041043.

References

Chen C, Chang Y, Liu C, Chang K, Guo I . Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat. 2006; 98(2):121-32. DOI: 10.1007/s10549-005-9139-y. View

Fujimoto A, Akifusa S, Kamio N, Hirofuji T, Nonaka K, Yamashita Y . Involvement of mTOR in globular adiponectin-induced generation of reactive oxygen species. Free Radic Res. 2009; 44(2):128-34. DOI: 10.3109/10715760903348328. View

Binai N, Damert A, Carra G, Steckelbroeck S, Lower J, Lower R . Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells. Int J Cancer. 2009; 127(1):55-66. DOI: 10.1002/ijc.25010. View

Lee M, Klein R, El-Shewy H, Luttrell D, Luttrell L . The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry. 2008; 47(44):11682-92. PMC: 2665882. DOI: 10.1021/bi801451f. View

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

Kang J, Lee Y, Yu B, Yang B, Cho K, Yoon D . Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res. 2005; 28(11):1263-9. DOI: 10.1007/BF02978210. View

Frankenberry K, Skinner H, Somasundar P, McFadden D, Vona-Davis L . Leptin receptor expression and cell signaling in breast cancer. Int J Oncol. 2006; 28(4):985-93. View

Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, Nagawa H . Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res. 2008; 149(1):9-14. DOI: 10.1016/j.jss.2007.10.012. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Nakayama S, Miyoshi Y, Ishihara H, Noguchi S . Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat. 2007; 112(3):405-10. DOI: 10.1007/s10549-007-9874-3. View

11.

Moon H, Dalamaga M, Kim S, Polyzos S, Hamnvik O, Magkos F . Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev. 2013; 34(3):377-412. PMC: 3660716. DOI: 10.1210/er.2012-1053. View

12.

Dieudonne M, Bussiere M, Santos E, Leneveu M, Giudicelli Y, Pecquery R . Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun. 2006; 345(1):271-9. DOI: 10.1016/j.bbrc.2006.04.076. View

13.

Chlebowski R, Aiello E, McTiernan A . Weight loss in breast cancer patient management. J Clin Oncol. 2002; 20(4):1128-43. DOI: 10.1200/JCO.2002.20.4.1128. View

14.

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

15.

Khandekar M, Cohen P, Spiegelman B . Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011; 11(12):886-95. DOI: 10.1038/nrc3174. View

16.

Lopez Fontana C, Maselli Artola M, Di Milta Monaco N, Recalde Rincon G, Vanrell Rodriguez M, Uvilla Recupero A . [Influence of leptin and adiponectin on prostate cancer]. Arch Esp Urol. 2009; 62(2):103-8. DOI: 10.4321/s0004-06142009000200003. View

17.

Tomlinson G, Chen T, Stastny V, Virmani A, Spillman M, Tonk V . Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 1998; 58(15):3237-42. View

18.

Naviglio S, Di Gesto D, Romano M, Sorrentino A, Illiano F, Sorvillo L . Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells. Cancer Biol Ther. 2009; 8(12):1183-90. DOI: 10.4161/cbt.8.12.8562. View

19.

Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M . Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta. 2002; 1592(2):107-16. DOI: 10.1016/s0167-4889(02)00276-8. View

20.

Gonzalez R, Cherfils S, Escobar M, Yoo J, Carino C, Styer A . Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem. 2006; 281(36):26320-8. DOI: 10.1074/jbc.M601991200. View